Cue Biopharma (CUE) SEC Filings & 10K Form → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free CUE Stock Alerts $1.41 -0.01 (-0.70%) (As of 04/25/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Recent Cue Biopharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView03/28/20243:29 PMCue Biopharma (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 03/11/20245:40 PMBleichroeder LP (Filed by)Cue Biopharma (Subject)Form SC 13G02/07/20244:09 PMBlackRock Inc. (Filed by)Cue Biopharma (Subject)Form SC 13G01/31/20241:08 PMBlackRock Inc. (Filed by)Cue Biopharma (Subject)Form SC 13G01/04/20243:00 PMCue Biopharma (Issuer)Morich Frank (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/04/20243:01 PMCue Biopharma (Issuer)Verheyen Patrick (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/04/20243:02 PMCue Biopharma (Issuer)DRISCOLL FREDERICK W (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/04/20243:02 PMCue Biopharma (Issuer)Kiener Peter A (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/04/20243:02 PMCue Biopharma (Issuer)Garzone Pamela (Reporting)Form 4Statement of changes in beneficial ownership of securities 09/14/20233:01 PMCue Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/25/202311:25 AMCue Biopharma (Issuer)Suri Anish (Reporting)Form 4Statement of changes in beneficial ownership of securities 07/25/202311:27 AMCue Biopharma (Issuer)Sandercock Colin (Reporting)Form 4Statement of changes in beneficial ownership of securities 07/25/202311:28 AMCue Biopharma (Issuer)PASSERI DANIEL R (Reporting)Form 4Statement of changes in beneficial ownership of securities 07/25/202311:31 AMCue Biopharma (Issuer)Millar Kerri-Ann (Reporting)Form 4Statement of changes in beneficial ownership of securities 07/25/202311:33 AMCue Biopharma (Issuer)Levisetti Matteo (Reporting)Form 4Statement of changes in beneficial ownership of securities 06/09/20233:31 PMCue Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/29/202311:15 PMCue Biopharma (Filer)Form EFFECT05/09/20234:27 PMCue Biopharma (Filer)Form S-3Registration statement under Securities Act of 1933 04/28/20233:07 PMCue Biopharma (Filer)Form DEFA14A04/25/20236:57 AMCue Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: VTVT SEC Filings ASMB SEC Filings CRVS SEC Filings CARM SEC Filings DERM SEC Filings YS SEC Filings HOOK SEC Filings TPST SEC Filings ANEB SEC Filings CNTB SEC Filings SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:CUE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
